<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.cpementalhealth.com/feeds/mostaccessed/journal?quantity=&amp;format=rss&amp;version=">
        <title>Clinical Practice and Epidemiology in Mental Health - Most accessed articles</title>
        <link>http://www.cpementalhealth.com</link>
        <description>The most accessed research articles published by Clinical Practice and Epidemiology in Mental Health</description>
        <dc:date>2009-06-26T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.cpementalhealth.com/content/3/1/21" />
                                <rdf:li rdf:resource="http://www.cpementalhealth.com/content/4/1/25" />
                                <rdf:li rdf:resource="http://www.cpementalhealth.com/content/5/1/15" />
                                <rdf:li rdf:resource="http://www.cpementalhealth.com/content/4/1/9" />
                                <rdf:li rdf:resource="http://www.cpementalhealth.com/content/5/1/14" />
                                <rdf:li rdf:resource="http://www.cpementalhealth.com/content/5/1/13" />
                                <rdf:li rdf:resource="http://www.cpementalhealth.com/content/5/1/16" />
                                <rdf:li rdf:resource="http://www.cpementalhealth.com/content/5/1/7" />
                                <rdf:li rdf:resource="http://www.cpementalhealth.com/content/5/1/8" />
                                <rdf:li rdf:resource="http://www.cpementalhealth.com/content/1/1/14" />
                            </rdf:Seq>
        </items>
        <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.cpementalhealth.com/content/3/1/21">
        <title>The impact of prescribed psychotropics on youth</title>
        <description>Many psychotropics prescribed to children are unlicensed or off-label. This article uses the two most prescribed psychotropics (MPH and SSRIs) to illustrate various concerns about their impact on youth. Many mental illnesses begin in childhood or early adulthood, warranting a treatment of some kind. However, commentators have argued that prescribing is influenced by five myths: (1) children are little adults; (2) children have no reason to develop depression or anxiety; (3) psychiatric disorders are the same across adults and children; (3) children can be prescribed lower doses of the same drug; (5) drugs are preferable to alternative treatments and are more successful. Several lines of evidence suggest that these are incorrect assumptions. We update readers with recent research in relation to these myths, concluding that researchers should clarify child/adult differences for psychotropics, attend to the growth of &quot;cosmetic&quot; use of psychotropics in children and adolescents, and address concerns about the diagnostic validity of mental illness in the current DSM classification system.</description>
        <link>http://www.cpementalhealth.com/content/3/1/21</link>
                <dc:creator>Shaheen Lakhan</dc:creator>
                <dc:creator>Gareth Hagger-Johnson</dc:creator>
                <dc:source>Clinical Practice and Epidemiology in Mental Health 2007, 3:21</dc:source>
        <dc:date>2007-10-20T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1745-0179-3-21</dc:identifier>
        <prism:publicationName>Clinical Practice and Epidemiology in Mental Health</prism:publicationName>
        <prism:issn>1745-0179</prism:issn>
        <prism:volume>3</prism:volume>
        <prism:startingPage>21</prism:startingPage>
        <prism:publicationDate>2007-10-20T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cpementalhealth.com/content/4/1/25">
        <title>Effects of transcendental meditation on mental health: a before-after study</title>
        <description>Background:
Transcendental Meditation is a mental practice to put the body and mind into a state of relaxation and rest. The method was shown to reduce anxiety and stress in previous reports. This study investigates its potential benefits in enhancing mental health of an adult Muslim population.
Methods:
A before-after clinical trial was conducted to evaluate the effect of a 12-week meditation course on mental health of participants who were enrolled into the study by random sampling. 28-item General Health Questionnaire (GHQ) was administered on two occasions in conjunction with a background data sheet.
Results:
Mean age of participants was 32.4; they were 70% female and 55% married. GHQ scores improved significantly after the meditation course (p value: &lt; 0.001). The difference was also significant in all subgroups of the population studied. In subclass analysis of the GHQ results, the before-after score improvement was significant only in the areas of somatisation (p value: &lt; 0.001) and anxiety (p value: &lt; 0.001).
Conclusion:
Transcendental Meditation may improve mental health of young adult population especially in the areas of somatisation and anxiety, and this effect seems to be independent of age, sex and marital status.</description>
        <link>http://www.cpementalhealth.com/content/4/1/25</link>
                <dc:creator>Masud Yunesian</dc:creator>
                <dc:creator>Afshin Aslani</dc:creator>
                <dc:creator>Javad Vash</dc:creator>
                <dc:creator>Abbas Bagheri Yazdi</dc:creator>
                <dc:source>Clinical Practice and Epidemiology in Mental Health 2008, 4:25</dc:source>
        <dc:date>2008-11-01T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1745-0179-4-25</dc:identifier>
        <prism:publicationName>Clinical Practice and Epidemiology in Mental Health</prism:publicationName>
        <prism:issn>1745-0179</prism:issn>
        <prism:volume>4</prism:volume>
        <prism:startingPage>25</prism:startingPage>
        <prism:publicationDate>2008-11-01T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cpementalhealth.com/content/5/1/15">
        <title>Adjustment Disorder: epidemiology, diagnosis and treatment</title>
        <description>Background:
Adjustment Disorder is a condition strongly tied to acute and chronic stress. Despite clinical suggestion of a large prevalence in the general population and the high frequency of its diagnosis in the clinical settings, there has been relatively little research reported and, consequently, very few hints about its treatments.
Methods:
the authors gathered old and current information on the epidemiology, clinical features, comorbidity, treatment and outcome of adjustment disorder by a systematic review of essays published on PUBMED.
Results:
After a first glance at its historical definition and its definition in the DSM and ICD systems, the problem of distinguishing AD from other mood and anxiety disorders, the difficulty in the definition of stress and the implied concept of &apos;vulnerability&apos; are considered. Comorbidity of AD with other conditions, and outcome of AD are then analyzed. This review also highlights recent data about trends in the use of antidepressant drugs, evidence on their efficacy and the use of psychotherapies.
Conclusion:
AD is a very common diagnosis in clinical practice, but we still lack data about its rightful clinical entity. This may be caused by a difficulty in facing, with a purely descriptive methods, a &quot;pathogenic label&quot;, based on a stressful event, for which a subjective impact has to be considered. We lack efficacy surveys concerning treatment. The use of psychotropic drugs such as antidepressants, in AD with anxious or depressed mood is not properly supported and should be avoided, while the usefulness of psychotherapies is more solidly supported by clinical evidence. To better determine the correct course of therapy, randomized-controlled trials, even for the combined use of drugs and psychotherapies, are needed vitally, especially for the resistant forms of AD.</description>
        <link>http://www.cpementalhealth.com/content/5/1/15</link>
                <dc:creator>Mauro Giovanni Carta</dc:creator>
                <dc:creator>Matteo Balestrieri</dc:creator>
                <dc:creator>Andrea Murru</dc:creator>
                <dc:creator>Maria Carolina Hardoy</dc:creator>
                <dc:source>Clinical Practice and Epidemiology in Mental Health 2009, 5:15</dc:source>
        <dc:date>2009-06-26T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1745-0179-5-15</dc:identifier>
        <prism:publicationName>Clinical Practice and Epidemiology in Mental Health</prism:publicationName>
        <prism:issn>1745-0179</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>15</prism:startingPage>
        <prism:publicationDate>2009-06-26T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cpementalhealth.com/content/4/1/9">
        <title>Animal-assisted therapy with farm animals for persons with psychiatric disorders: Effects on self-efficacy, coping ability and quality of life, a randomized controlled trial</title>
        <description>Background:
The benefits of Animal-Assisted Therapy (AAT) for humans with mental disorders have been well-documented using cats and dogs, but there is a complete lack of controlled studies using farm animals as therapeutic agents for psychiatric patients. The study was developed in the context of Green care, a concept that involves the use of farm animals, plants, gardens, or the landscape in recreational or work-related interventions for different target groups of clients in cooperation with health authorities. The present study aimed at examining effects of a 12-week intervention with farm animals on self-efficacy, coping ability and quality of life among adult psychiatric patients with a variety of psychiatric diagnoses.
Methods:
The study was a randomized controlled trial and follow-up. Ninety patients (59 women and 31 men) with schizophrenia, affective disorders, anxiety, and personality disorders completed questionnaires to assess self-efficacy (Generalized Self-Efficacy Scale; GSE), coping ability (Coping Strategies Scale), and quality of life (Quality of Life Scale; QOLS-N) before, at the end of intervention, and at six months follow-up. Two-thirds of the patients (N = 60) were given interventions; the remaining served as controls.
Results:
There was significant increase in self-efficacy in the treatment group but not in the control group from before intervention (SB) to six months follow-up (SSMA), (SSMA-SB; F1,55 = 4.20, p= 0.05) and from end of intervention (SA) to follow-up (SSMA-SA; F1,55 = 5.6, p= 0.02). There was significant increase in coping ability within the treatment group between before intervention and follow-up (SSMA-SB = 2.7, t = 2.31, p = 0.03), whereas no changes in quality of life was found. There were no significant changes in any of the variables during the intervention.
Conclusion:
AAT with farm animals may have positive influences on self-efficacy and coping ability among psychiatric patients with long lasting psychiatric symptoms.</description>
        <link>http://www.cpementalhealth.com/content/4/1/9</link>
                <dc:creator>Bente Berget</dc:creator>
                <dc:creator>Oivind Ekeberg</dc:creator>
                <dc:creator>Bjarne Braastad</dc:creator>
                <dc:source>Clinical Practice and Epidemiology in Mental Health 2008, 4:9</dc:source>
        <dc:date>2008-04-11T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1745-0179-4-9</dc:identifier>
        <prism:publicationName>Clinical Practice and Epidemiology in Mental Health</prism:publicationName>
        <prism:issn>1745-0179</prism:issn>
        <prism:volume>4</prism:volume>
        <prism:startingPage>9</prism:startingPage>
        <prism:publicationDate>2008-04-11T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cpementalhealth.com/content/5/1/14">
        <title>Anticonvulsants in the treatment of aggression in the demented elderly: an update
</title>
        <description>IntroductionComplex psychopathological and behavioral symptoms, such as delusions and aggression against care providers, are often the primary cause of acute hospital admissions of elderly patients to emergency units and psychiatric departments. This issue resembles an interdisciplinary clinically highly relevant diagnostic and therapeutic challenge across many medical subjects and general practice. At least 50% of the dramatically growing number of patients with dementia exerts aggressive and agitated symptoms during the course of clinical progression, particularly at moderate clinical severity.
Methods:
Commonly used rating scales for agitation and aggression are reviewed and discussed. Furthermore, we focus in this article on benefits and limitations of all available data of anticonvulsants published in this specific indication, such as valproate, carbamazepine, oxcarbazepine, lamotrigine, gabapentin and topiramate.
Results:
To date, most positive and robust data are available for carbamazepine, however, pharmacokinetic interactions with secondary enzyme induction limit its use. Controlled data of valproate do not seem to support the use in this population. For oxcarbazepine only one controlled but negative trial is available. Positive small series and case reports have been reported for lamotrigine, gabapentin and topiramate.
Conclusion:
So far, data of anticonvulsants in demented patients with behavioral disturbances are not convincing. Controlled clinical trials using specific, valid and psychometrically sound instruments of newer anticonvulsants with a better tolerability profile are mandatory to verify whether they can contribute as treatment option in this indication.</description>
        <link>http://www.cpementalhealth.com/content/5/1/14</link>
                <dc:creator>Benedikt Amann</dc:creator>
                <dc:creator>Johannes Pantel</dc:creator>
                <dc:creator>Heinz Grunze</dc:creator>
                <dc:creator>Eduard Vieta</dc:creator>
                <dc:creator>Francesc Colom</dc:creator>
                <dc:creator>Anamaria Gonzalez-Pinto</dc:creator>
                <dc:creator>Dieter Naber</dc:creator>
                <dc:creator>Harald Hampel</dc:creator>
                <dc:source>Clinical Practice and Epidemiology in Mental Health 2009, 5:14</dc:source>
        <dc:date>2009-06-16T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1745-0179-5-14</dc:identifier>
        <prism:publicationName>Clinical Practice and Epidemiology in Mental Health</prism:publicationName>
        <prism:issn>1745-0179</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>14</prism:startingPage>
        <prism:publicationDate>2009-06-16T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cpementalhealth.com/content/5/1/13">
        <title>Bipolar Disorder: an impossible diagnosis</title>
        <description>Following the recent debates on the discrepancy between the predominant weight of bipolar disorder (BPD) in the clinical reality and its relatively low prevalence figures emerging from epidemiological surveys, the present paper contends the ability of current operational diagnostic system to properly detect the clinical entity of bipolar disorder.As an episode of mania/hypomania is the necessary requirement for a diagnosis of bipolar disorder to be made, in this editorial we maintain that: a) the most severe forms of mania, characterized by cloudy consciousness, mood incongruent delusions, and physical symptoms are likely to escape DSM IV criteria, that are shaped around hypomania or mild mania; b) the impossibility to diagnose mania when this occurs during antidepressant treatments impedes diagnosing those cases whose natural illness pattern is Depression followed by Mania (known as DMI pattern); c) given that approximately 50% of cases have their onset of BPD with affective episodes other than mania/hypomania any prevalence figure necessarily underestimates BPD; d) the sub-threshold forms of BPD, well described in the concept of Bipolar Spectrum, are beyond the possibility to be recognized using operational diagnoses in spite of their utmost clinical relevance.</description>
        <link>http://www.cpementalhealth.com/content/5/1/13</link>
                <dc:creator>Carlo Faravelli</dc:creator>
                <dc:creator>Silvia Gorini Amedei</dc:creator>
                <dc:creator>Maria Alessandra Scarpato</dc:creator>
                <dc:creator>Luca Faravelli</dc:creator>
                <dc:source>Clinical Practice and Epidemiology in Mental Health 2009, 5:13</dc:source>
        <dc:date>2009-06-16T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1745-0179-5-13</dc:identifier>
        <prism:publicationName>Clinical Practice and Epidemiology in Mental Health</prism:publicationName>
        <prism:issn>1745-0179</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>13</prism:startingPage>
        <prism:publicationDate>2009-06-16T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cpementalhealth.com/content/5/1/16">
        <title>Gluten encephalopathy with psychiatric onset: case report </title>
        <description>Many cases of coeliac disease, a gastrointestinal autoimmune disorder caused by sensitivity to gluten, can remain in a subclinical stage or undiagnosed. In a significant proportion of cases (10&#8211;15%) gluten intolerance can be associated with central or peripheral nervous system and psychiatric disorders.A 38-year-old man was admitted as to our department an inpatient for worsening anxiety symptoms and behavioural alterations. After the addition of second generation antipsychotic to the therapeutic regimen, the patient presented neuromotor impairment with high fever, sopor, leukocytosis, raised rhabdomyolysis-related indicators. Neuroleptic malignant syndrome was strongly suspected. After worsening of his neuropsychiatric conditions, with the onset of a frontal cognitive deficit, bradykinesia and difficulty walking, dysphagia, anorexia and hypoferraemic anaemia, SPET revealed a reduction of cerebral perfusion and ENeG results were compatible with a mainly motor polyneuropathy. Extensive laboratory investigations gave positive results for anti-gliadin antibodies, and an appropriate diet led to a progressive remission of the encephalopathy.</description>
        <link>http://www.cpementalhealth.com/content/5/1/16</link>
                <dc:creator>Nicola Poloni</dc:creator>
                <dc:creator>Simone Vender</dc:creator>
                <dc:creator>Emilio Bolla</dc:creator>
                <dc:creator>Paola Bortolaso</dc:creator>
                <dc:creator>Chiara Costantini</dc:creator>
                <dc:creator>Camilla Callegari</dc:creator>
                <dc:source>Clinical Practice and Epidemiology in Mental Health 2009, 5:16</dc:source>
        <dc:date>2009-06-26T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1745-0179-5-16</dc:identifier>
        <prism:publicationName>Clinical Practice and Epidemiology in Mental Health</prism:publicationName>
        <prism:issn>1745-0179</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>16</prism:startingPage>
        <prism:publicationDate>2009-06-26T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cpementalhealth.com/content/5/1/7">
        <title>Epidemilogical and clincial use of  GMHAT-PC ( Global Mental Health assessment  tool- primary care )in cardiac patients</title>
        <description>Background:
A computer assisted interview, the GMHAT/PC has been developed to assist General Practitioners and other Health Professionals to make a quick, convenient and comprehensive standardised mental health assessment. It has proved to be a reliable and valid tool in our previous studies involving General Practitioners and Nurses. Little is known about its use in cardiac rehabilitation settings.AimThe study aims to assess the feasibility of using a computer assisted diagnostic interview by nurses for patients attending Cardiac Rehabilitation Clinics and to examine the level of agreement between the GMHAT/PC diagnosis and a Psychiatrist clinical diagnosis. Prevalence of mental illness was also measured.DesignCross sectional validation and feasibility study.
Methods:
Nurses using GMHAT/PC examined consecutive patients presenting to a cardiac rehabilitation centre. A total of 118 patients were assessed by nurses and consultant psychiatrist in cardiac rehabilitation centres. The kappa coefficient (&#954;), sensitivity, and specificity of the GMHAT/PC diagnosis were analysed as measures of validity. The time taken for the interview as well as feedback from patients and interviewers were indicators of feasibility. Data on prevalence of mental disorders in an outpatient cardiac rehabilitation setting was collected.
Results:
The mean duration of the interview was 14 minutes. Feedback from patients and interviewers indicated good practical feasibility. The agreement between GMHAT/PC interview-based diagnoses and consultant psychiatrists&apos; ICD-10 criteria-based clinical diagnosis was good or excellent (&#954; = 0.76, sensitivity = 0.73, specificity = 0.90). The prevalence of mental disorders in this group was 22%, predominantly depression. Very few cases were on treatment.
Conclusion:
GMHAT/PC can assist nurses in making accurate mental health assessments and diagnoses in a cardiac rehabilitation setting and is acceptable to cardiac patients. It can successfully be used to gather epidemiological data and help in managing mental health problems in this group of patients.</description>
        <link>http://www.cpementalhealth.com/content/5/1/7</link>
                <dc:creator>Murali Krishna</dc:creator>
                <dc:creator>Peter Lepping</dc:creator>
                <dc:creator>Vimal Sharma</dc:creator>
                <dc:creator>John Copeland</dc:creator>
                <dc:creator>Lorraine Lockwood</dc:creator>
                <dc:creator>Margaret Williams</dc:creator>
                <dc:source>Clinical Practice and Epidemiology in Mental Health 2009, 5:7</dc:source>
        <dc:date>2009-04-13T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1745-0179-5-7</dc:identifier>
        <prism:publicationName>Clinical Practice and Epidemiology in Mental Health</prism:publicationName>
        <prism:issn>1745-0179</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>7</prism:startingPage>
        <prism:publicationDate>2009-04-13T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cpementalhealth.com/content/5/1/8">
        <title>Intimate partner violence and depression among women in rural Ethiopia: a cross-sectional study</title>
        <description>Background:
Studies from high-income countries have shown intimate partner violence to be associated with depression among women. The present paper examines whether this finding can be confirmed in a very different cultural setting in rural Ethiopia.MethodA community-based cross-sectional study was undertaken in Ethiopia among 1994 currently married women. Using the Composite International Diagnostic Interview (CIDI), cases of depressive episode were identified according to the ICD-10 diagnosis. Using a standardized questionnaire, women who experienced violence by an intimate partner were identified. A multivariate analysis was conducted between the explanatory variables and depressive status of the women, after adjusting for possible confounders.
Results:
The 12-month prevalence of depressive episode among the women was 4.8% (95% CI, 3.9% and 5.8%), while the lifetime prevalence of any form of intimate partner violence was 72.0% (95% CI, 70.0% and 73.9%). Physical violence (OR = 2.56, 95% CI, 1.61, 4.06), childhood sexual abuse (OR = 2.00, 95% CI, 1.13, 3.56), mild emotional violence (OR = 3.19, 95% CI, 1.98, 5.14), severe emotional violence (OR = 3.90, 95% CI, 2.20, 6.93) and high spousal control of women (OR = 3.30, 95% CI, 1.58, 6.90) by their partners were independently associated with depressive episode, even after adjusting for socioeconomic factors.
Conclusion:
The high prevalence of intimate partner violence, a factor often obscured within general life event categories, requires attention to consider it as an independent factor for depression, and thus to find new possibilities of prevention and treatment in terms of public health strategies, interventions and service provision.</description>
        <link>http://www.cpementalhealth.com/content/5/1/8</link>
                <dc:creator>Negussie Deyessa</dc:creator>
                <dc:creator>Yemane Berhane</dc:creator>
                <dc:creator>Atalay Alem</dc:creator>
                <dc:creator>Mary Ellsberg</dc:creator>
                <dc:creator>Maria Emmelin</dc:creator>
                <dc:creator>Ulf Hogberg</dc:creator>
                <dc:creator>Gunnar Kullgren</dc:creator>
                <dc:source>Clinical Practice and Epidemiology in Mental Health 2009, 5:8</dc:source>
        <dc:date>2009-04-28T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1745-0179-5-8</dc:identifier>
        <prism:publicationName>Clinical Practice and Epidemiology in Mental Health</prism:publicationName>
        <prism:issn>1745-0179</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>8</prism:startingPage>
        <prism:publicationDate>2009-04-28T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cpementalhealth.com/content/1/1/14">
        <title>The distribution of the common mental disorders: social inequalities in Europe</title>
        <description>Background:
The social class distribution of the common mental disorders (mostly anxiety and/or depression) has been in doubt until recently. This paper reviews the evidence of associations between the prevalence of the common mental disorders in adults of working age and markers of socio-economic disadvantage.
Methods:
Work is reviewed which brings together major population surveys from the last 25 years, together with work trawling for all European population studies. Data from more recent studies is examined, analysed and discussed. Because of differences in methods, instruments and analyses, little can be compared precsiely, but internal associations can be examined.FindingsPeople of lower socio-economic status, however measured, are disadvantaged, and this includes higher frequencies of the conditions now called the &apos;common mental disorders&apos; (mostly non-psychotic depression and anxiety, either separately or together). In European and similar developed populations, relatively high frequencies are associated with poor education, material disadvantage and unemployment.
Conclusion:
The large contribution of the common mental disorders to morbidity and disability, and the social consequences in working age adults would justify substantial priority being given to addressing mental health inequalities, and deprivation in general, within national and European social and economic policy.</description>
        <link>http://www.cpementalhealth.com/content/1/1/14</link>
                <dc:creator>Tom Fryers</dc:creator>
                <dc:creator>David Melzer</dc:creator>
                <dc:creator>Rachel Jenkins</dc:creator>
                <dc:creator>Traolach Brugha</dc:creator>
                <dc:source>Clinical Practice and Epidemiology in Mental Health 2005, 1:14</dc:source>
        <dc:date>2005-09-05T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1745-0179-1-14</dc:identifier>
        <prism:publicationName>Clinical Practice and Epidemiology in Mental Health</prism:publicationName>
        <prism:issn>1745-0179</prism:issn>
        <prism:volume>1</prism:volume>
        <prism:startingPage>14</prism:startingPage>
        <prism:publicationDate>2005-09-05T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
